# Epilepsy Market Set to Grow During the Forecast Period (2026-2036) as Novel Antiseizure Therapies Gain Momentum | DelveInsight

- Source: PR Newswire
- Published: 2026-10-27T14:31:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/epilepsy-market-set-to-grow-during-the-forecast-period-20262036-as-novel-antiseizure-therapies-gain-momentum--delveinsight-302920281.html
- Canonical: https://groundlevelnews.com/story/epilepsy-market-set-to-grow-during-the-forecast-period-2026-2036-as-no-ca0ef6/

The epilepsy market is expected to grow due to an increase in disease prevalence and the expected launch of emerging therapies, including Azetukalner (XEN1101; Xenon Pharmaceuticals), ABS-1230 (Actio Biosciences), BHV-7000 (Biohaven Pharmaceuticals), Relutrigine (PRAX-562; Praxis...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire._